Skip to content

Multiform-based Baduanjin Exercise Prescription for Idiopathic Pulmonary Fibrosis disease (IPF) : study protocol for a randomized controlled trial

Multiform-based Baduanjin Exercise Prescription for Idiopathic Pulmonary Fibrosis disease (IPF) : study protocol for a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005533
Enrollment
Unknown
Registered
2022-01-12
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Pulmonary Fibrosis disease

Interventions

Sponsors

Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) age between 35 and 80; (2) The clinical symptoms were stable in the last two months; (3) Patients diagnosed with IPF who satisfied the diagnostic criteria of ATS/ERS/JRS/ALAT 2018 [According to past medical history, laboratory tests and HRCT (typical UIP and Probable UIP)]; (4) Have not participated in other sports training systematically or intermittently in the last six months (no more than twice a week); (5) No other disabling diseases (e.g. stroke, Parkinson's disease, etc.); (6) Patients who agree to sign written informed consent.

Exclusion criteria

Exclusion criteria: (1) other chronic respiratory diseases; (2) serious complications, including cardiovascular, liver or kidney disease; (3) Inpatients whose condition is rapidly aggravating or in urgent need of other medication management; (4) Skeletal muscle diseases or other diseases that may affect muscle strength assessment.

Design outcomes

Primary

MeasureTime frame
Pulmonary function;Six minutes walking distan (6MWD);HRCT change (HRCT score);

Secondary

MeasureTime frame
St. George Respiratory Questionnaire (SGRQ);modified British Medical Research Council (mMRC);

Countries

China

Contacts

Public ContactLiangji Liu
llj6505@163.com15870673696

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026